CBMX / CombiMatrix Corp. - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

CBMX / CombiMatrix Corp. / Stonepine Capital Management, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* CombiMatrix Corporation (Name of Issuer) common stock, $0.001 par value (Title of Class of Securities) 20009T501 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule purs

CBMX / CombiMatrix Corp. 15-12B

15-12B OMB APPROVAL OMB Number: 3235-0167 Expires: March 31, 2018 Estimated average burden hours per response.

CBMX / CombiMatrix Corp. S-8 POS

S-8 POS As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

CBMX / CombiMatrix Corp. S-8 POS

S-8 POS 1 d497326ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on November 27, 2017 Registration No. 333-145704 Registration No. 333-190534 Registration No. 333-193302 Registration No. 333-197322 Registration No. 333-205580 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-1457

CBMX / CombiMatrix Corp. S-8 POS

S-8 POS 1 d497326ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on November 27, 2017 Registration No. 333-145704 Registration No. 333-190534 Registration No. 333-193302 Registration No. 333-197322 Registration No. 333-205580 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-1457

CBMX / CombiMatrix Corp. S-8 POS

S-8 POS 1 d497326ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on November 27, 2017 Registration No. 333-145704 Registration No. 333-190534 Registration No. 333-193302 Registration No. 333-197322 Registration No. 333-205580 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-1457

CBMX / CombiMatrix Corp. S-8 POS

S-8 POS 1 d497326ds8pos.htm S-8 POS As filed with the Securities and Exchange Commission on November 27, 2017 Registration No. 333-145704 Registration No. 333-190534 Registration No. 333-193302 Registration No. 333-197322 Registration No. 333-205580 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-1457

CBMX / CombiMatrix Corp. POS AM

POS AM As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

CBMX / CombiMatrix Corp. POS AM

POS AM As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

CBMX / CombiMatrix Corp. POS AM

POS AM As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

CBMX / CombiMatrix Corp. POS AM

POS AM As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

CBMX / CombiMatrix Corp. POS AM

POS AM As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

CBMX / CombiMatrix Corp. POS AM

POS AM As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

CBMX / CombiMatrix Corp. POS AM

POS AM As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

CBMX / CombiMatrix Corp. POS AM

POS AM As filed with the Securities and Exchange Commission on November 27, 2017 Registration No.

Amended and Restated Certificate of Incorporation of the Company.

EX-3.1 Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF COMBIMATRIX CORPORATION ARTICLE I The name of the corporation is CombiMatrix Corporation. ARTICLE II The address of the registered office of the corporation in the State of Delaware is Corporation Trust Center, 1209 Orange Street, City of Wilmington, County of New Castle, Zip Code 19801, and the name of the registered agent of

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets

Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2017 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Commission (IRS Emplo

Amended and Restated Bylaws of the Company.

EX-3.2 Exhibit 3.2 AMENDED AND RESTATED BYLAWS OF COMBIMATRIX CORPORATION TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 1.1 Principal Office 1 1.2 Other Offices 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 Place Of Meetings 1 2.2 Annual Meeting 1 2.3 Special Meeting 1 2.4 Notice of Stockholders? Meetings 2 2.5 Manner of Giving Notice; Affidavit of Notice 2 2.6 Quorum 2 2.7 Adjourned Meeting;

NVTA / Invitae Corp. SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 4 to SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company (Issuer)) Invitae Corporation (Name of Filing Person (Offeror)) Series F Warrants to Purchase Common Stock, Par Value $0.001 P

COMBIMATRIX CORPORATION STOCKHOLDERS APPROVE MERGER AGREEMENT WITH INVITAE CORPORATION

COMBIMATRIX CORPORATION STOCKHOLDERS APPROVE MERGER AGREEMENT WITH INVITAE CORPORATION IRVINE, Calif.

Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 10, 2017 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Commission (IRS Employer of In

CBMX / CombiMatrix Corp. 4D9/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement under Section 14(d)(4) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company) CombiMatrix Corporation (Names of Persons Filing Statement) Series F Warrants to Purchase Common Stock, Par Value $0.001 Per Shar

NVTA / Invitae Corp. SC TO-T/A

SC TO-T/A 1 d480715dsctota.htm SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company (Issuer)) Invitae Corporation (Name of Filing Person (Offeror)) Series F Warrants to Purchase C

Invitae Corporation Issues Reminder Regarding Exchange Offer for CombiMatrix Corporation Series F Warrants Exchange Offer to Expire One Minute After 11:59 p.m., New York City Time, on November 13, 2017, Unless Extended

EX-(a)(1)(F) Exhibit (a)(1)(F) Invitae Corporation Issues Reminder Regarding Exchange Offer for CombiMatrix Corporation Series F Warrants Exchange Offer to Expire One Minute After 11:59 p.

NVTA / Invitae Corp. 425 (Prospectus)

425 Filed by Invitae Corporation Pursuant to Rule 425 under the Securities Act of 1933, as amended Subject Company: CombiMatrix Corporation Commission File Number: 001-33523 Date: November 8, 2017 Invitae Corporation Issues Reminder Regarding Exchange Offer for CombiMatrix Corporation Series F Warrants Exchange Offer to Expire One Minute After 11:59 p.

CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results

CombiMatrix Corporation Reports Third Quarter 2017 Financial and Operating Results IRVINE, Calif.

Results of Operations and Financial Condition, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction (Commissio

CBMX / CombiMatrix Corp. 10-Q (Quarterly Report)

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarterly Period Ended September 30, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 0

CombiMatrix 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ]

Other Events, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 1, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorpo

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote “FOR” the Proposed Merger with Invitae Corporation

EXHIBIT 99.1 Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote “FOR” the Proposed Merger with Invitae Corporation IRVINE, Calif. (November 1, 2017) – CombiMatrix Corporation (NASDAQ: CBMX) (“CombiMatrix” or the “Company”), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing

CombiMatrix (Prospectus)

425 1 form425.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (date of earliest event reported): November 1, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorpo

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote “FOR” the Proposed Merger with Invitae Corporation

EXHIBIT 99.1 Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend CombiMatrix Corporation Shareholders Vote “FOR” the Proposed Merger with Invitae Corporation IRVINE, Calif. (November 1, 2017) – CombiMatrix Corporation (NASDAQ: CBMX) (“CombiMatrix” or the “Company”), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing

CombiMatrix 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ]

CombiMatrix 14A

DEFA14A 1 defa14-a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Prelimin

CombiMatrix 4D9/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement under Section 14(d)(4) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company) CombiMatrix Corporation (Names of Persons Filing Statement) Series F Warrants to Purchase Common Stock, Par Value $0.001 Per Shar

Invitae SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company (Issuer)) Invitae Corporation (Name of Filing Person (Offeror)) Series F Warrants to Purchase Common Stock, Par Value $0.001 P

Prospectus Supplement No. 1 to the Prospectus/Offer to Exchange relating to shares of common stock of Invitae Corporation to be issued in the Exchange Offer (incorporated by reference to Prospectus Supplement No. 1 filed by Invitae Corporation with the SEC on October 23, 2017).

DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ?

CombiMatrix DEFM14A

DEFM14A 1 d411705ddefm14a.htm DEFM14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the

CombiMatrix 4D9/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement under Section 14(d)(4) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company) CombiMatrix Corporation (Names of Persons Filing Statement) Series F Warrants to Purchase Common Stock, Par Value $0.001 Per Shar

Invitae SC TO-T/A

SC TO-T/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company (Issuer)) Invitae Corporation (Name of Filing Person (Offeror)) Series F Warrants to Purchase Common Stock, Par Value $0.001 P

Marketing and Laboratory Services Agreement, dated as of September 25, 2017, by and among Invitae Corporation, Good Start Genetics, Inc. and CombiMatrix Molecular Diagnostics, Inc. (incorporated by reference to Exhibit 10.1 to CombiMatrix’s Current Report on Form 8-K filed on September 27, 2017).

MARKETING AND LABORATORY SERVICES AGREEMENT This Marketing and Laboratory Services Agreement (this “Agreement”) is made and entered into as of September 25, 2017 (the “Effective Date”) by and between CombiMatrix Molecular Diagnostics, Inc.

CombiMatrix (Prospectus)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 25, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi

Marketing and Laboratory Services Agreement dated as of September 25, 2017 by and between Invitae Corporation, Good Start Genetics, Inc. and CombiMatrix Molecular Diagnostics, Inc.

MARKETING AND LABORATORY SERVICES AGREEMENT This Marketing and Laboratory Services Agreement (this ?Agreement?) is made and entered into as of September 25, 2017 (the ?Effective Date?) by and between CombiMatrix Molecular Diagnostics, Inc.

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 25, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi

CombiMatrix (Prospectus)

425 1 form425.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 25, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorp

CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae

EX-99.1 2 ex99-1.htm CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae IRVINE, Calif. (September 25, 2017) – CombiMatrix Corporation (NASDAQ: CBMX) (“CombiMatrix” or the “Company”), a family health molecular diagnostics company specializing in DNA-based reproductive health and pediatric testing services, announced today it has set important d

CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae

CombiMatrix Sets Record Date and Special Stockholders Meeting Date Regarding Proposed Merger with Invitae IRVINE, Calif.

Other Events, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 25, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorp

CombiMatrix 4D9

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement under Section 14(d)(4) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company) CombiMatrix Corporation (Names of Persons Filing Statement) Series F Warrants to Purchase Common Stock, Par Value $0.001 Per Share (Title of Class o

Schedule TO filed by Invitae Corporation.

SC TO-T UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Subject Company (Issuer)) Invitae Corporation (Name of Filing Person (Offeror)) Series F Warrants to Purchase Common Stock, Par Value $0.001 Per Share (Title of Cl

CBMX / CombiMatrix Corp. / MMCAP International Inc. SPC Passive Investment

SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934 COMBIMATRIX CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 20009T501 (CUSIP Number) August 7, 2017 (Date of Event Which Requires Filing of This Statement) Check the Appropriate box to designate the rule pursuant to which this schedule is filed: ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) CUSIP No.

CBMX / CombiMatrix Corp. 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarterly Period Ended June 30, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 001-33523 COMBIMATRIX CORP

CBMX / CombiMatrix Corp. / Stonepine Capital Management, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* CombiMatrix Corporation (Name of Issuer) common stock, $0.001 par value (Title of Class of Securities) 20009T501 (CUSIP Number) August 2, 2017 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant

Results of Operations and Financial Condition, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorpora

CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results

CombiMatrix Corporation Reports Second Quarter 2017 Financial and Operating Results IRVINE, Calif.

AGREEMENT AND PLAN OF MERGER AND REORGANIZATION

EX-2.1 2 ex2-1.htm EXECUTION VERSION AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of July 31, 2017, by and among INVITAE CORPORATION, a Delaware corporation (“Invitae”), CORONADO MERGER SUB, INC., a Delaware corporation (“Merger Sub”), and COMBIMATRIX CORPORATION, a Delaware corporation (“CombiMa

CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock $27 million offered to holders of CombiMatrix Common Stock (Nasdaq: CBMX) subject to certain adjustments $6 million offered to ho

CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock $27 million offered to holders of CombiMatrix Common Stock (Nasdaq: CBMX) subject to certain adjustments $6 million offered to holders of CombiMatrix Series F Warrants (Nasdaq: CBMXW) IRVINE, Calif.

CombiMatrix (Prospectus)

425 1 form425.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 31, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporati

Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 31, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission Fi

CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock $27 million offered to holders of CombiMatrix Common Stock (Nasdaq: CBMX) subject to certain adjustments $6 million offered to ho

EX-99.1 3 ex99-1.htm CombiMatrix Enters Into Merger Agreement with Invitae Corporation to be Acquired for $33 Million in Invitae Common Stock $27 million offered to holders of CombiMatrix Common Stock (Nasdaq: CBMX) subject to certain adjustments $6 million offered to holders of CombiMatrix Series F Warrants (Nasdaq: CBMXW) IRVINE, Calif. (July 31, 2017) – CombiMatrix Corporation (NASDAQ: CBMX) (“

Agreement and Plan of Merger and Reorganization by and among the Company, Invitae and Merger Sub, dated as of July 31, 2017. Incorporated by reference to Exhibit 2.1 to the Company’s Current Report on Form 8-K (SEC File No. 001-33523) filed with the SEC on July 31, 2017.

EXECUTION VERSION AGREEMENT AND PLAN OF MERGER AND REORGANIZATION THIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of July 31, 2017, by and among INVITAE CORPORATION, a Delaware corporation (“Invitae”), CORONADO MERGER SUB, INC.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 14, 2017 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Commission (IRS

COMBIMATRIX CORPORATION AMENDED AND RESTATED 2017 EXECUTIVE PERFORMANCE BONUS PLAN

EX-10.1 2 ex10-1.htm Exhibit 10.1 COMBIMATRIX CORPORATION AMENDED AND RESTATED 2017 EXECUTIVE PERFORMANCE BONUS PLAN Purpose Pursuant to the authority granted under CombiMatrix Corporation Compensation Committee Charter, the Compensation Committee (the “Committee”) of CombiMatrix Corporation (the “Company” or “our”) has adopted this 2017 Executive Performance Bonus Plan (the “Plan”) effective as o

CombiMatrix (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarterly Period Ended March 31, 2017 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 001-33523 COMBIMATRIX COR

CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results Achieves record reproductive health revenues on higher test volumes and average revenue per test, expands gross margin, significantly narrows operating loss and report

EX-99.1 2 ex99-1.htm CombiMatrix Corporation Reports First Quarter 2017 Financial and Operating Results Achieves record reproductive health revenues on higher test volumes and average revenue per test, expands gross margin, significantly narrows operating loss and reports record cash collections Affirms outlook to reach positive cash flow from operations by the fourth quarter of 2017 Conference ca

Results of Operations and Financial Condition, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporatio

CombiMatrix 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted b

CombiMatrix 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted b

CombiMatrix (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO .

SUBSIDIARIES OF THE REGISTRANT

EX-21.1 2 ex21-1.htm EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT The following is a listing of the subsidiaries of CombiMatrix Corporation: Jurisdiction of Incorporation CombiMatrix Molecular Diagnostics, Inc. California

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) February 27, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorpo

Results of Operations and Financial Condition, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 22, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction) (Commiss

CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results Achieves record quarterly reproductive health revenues and test volume, across-the-board increases in average revenue per test, expanded gross margin, s

CombiMatrix Corporation Reports 2016 Fourth Quarter and Full Year Financial and Operating Results Achieves record quarterly reproductive health revenues and test volume, across-the-board increases in average revenue per test, expanded gross margin, significantly narrowed operating loss and record cash collections Affirms outlook to reach positive cash flow from operations by the fourth quarter of 2017 Conference call begins today at 4:30 p.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 31, 2017 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorpo

COMBIMATRIX CORPORATION 2017 EXECUTIVE PERFORMANCE BONUS PLAN

EX-10.1 2 ex10-1.htm Exhibit 10.1 COMBIMATRIX CORPORATION 2017 EXECUTIVE PERFORMANCE BONUS PLAN Purpose Pursuant to the authority granted under CombiMatrix Corporation Compensation Committee Charter, the Compensation Committee (the “Committee”) of CombiMatrix Corporation (the “Company” or “our”) has adopted this 2017 Executive Performance Bonus Plan (the “Plan”) effective as of January 1, 2017. Th

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 19, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorp

CombiMatrix (Quarterly Report)

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarterly Period Ended September 30, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 0

Results of Operations and Financial Condition, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 2, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorpo

CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results Rapidly growing revenue, increasing test volume, gross margin expansion, strong cash reimbursement and prudent expense management provide clear path to profitability C

EX-99.1 2 ex99-1.htm CombiMatrix Corporation Reports Third Quarter 2016 Financial and Operating Results Rapidly growing revenue, increasing test volume, gross margin expansion, strong cash reimbursement and prudent expense management provide clear path to profitability Conference call begins today at 4:30 p.m. Eastern time IRVINE, Calif. (November 2, 2016) – CombiMatrix Corporation (NASDAQ: CBMX),

CBMX / CombiMatrix Corp. / HAMILTON EDWARD ARTHUR - AMENDMENT NO. 2 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 2) Under the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 20009T303 (CUSIP Number) August 5, 2016 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursuant

CombiMatrix (Quarterly Report)

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarterly Period Ended June 30, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 001-33

CombiMatrix Corporation Reports Second Quarter 2016 Financial and Operating Results Revenue growth, gross margin expansion and strong cash reimbursement support progress toward goal of profitability Conference Call Begins Today at 4:30 p.m. Eastern T

EX-99.1 2 ex99-1.htm CombiMatrix Corporation Reports Second Quarter 2016 Financial and Operating Results Revenue growth, gross margin expansion and strong cash reimbursement support progress toward goal of profitability Conference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif. (August 3, 2016) – CombiMatrix Corporation (NASDAQ: CBMX), a family health molecular diagnostics company speci

CombiMatrix (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission

Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporat

COMBIMATRIX CORPORATION COMMON STOCK PURCHASE WARRANTS REPURCHASE AGREEMENT

EX-10.1 2 ex10-1.htm COMBIMATRIX CORPORATION COMMON STOCK PURCHASE WARRANTS REPURCHASE AGREEMENT THIS COMMON STOCK PURCHASE WARRANTS REPURCHASE AGREEMENT (this “Agreement”) is made as of July 11, 2016 (the “Effective Date”), by and between CombiMatrix Corporation, a Delaware corporation (the “Company”), and those certain holders of Common Stock Purchase Warrants set forth on the signature pages he

Submission of Matters to a Vote of Security Holders

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 16, 2016 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Commission (IRS

CombiMatrix AM

As filed with the Securities and Exchange Commission on May 13, 2016 Registration No.

CBMX / CombiMatrix Corp. / ACUTA CAPITAL PARTNERS, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 5)* COMBIMATRIX CORPORATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 20009T501 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authorized to Receive

8,000 Shares of Series F Convertible Preferred Stock (and 2,067,183 Shares of Common Stock Underlying the Series F Convertible Preferred Stock) 2,067,183 Warrants to Purchase up to 2,067,183 Shares of Common Stock (and 2,067,183 Shares of Common Stoc

424B3 1 form424b3.htm Filed pursuant to Rule 424(b)(3) Registration No. 333-208704 Prospectus Supplement No. 2 (To Prospectus dated March 21, 2016) 8,000 Shares of Series F Convertible Preferred Stock (and 2,067,183 Shares of Common Stock Underlying the Series F Convertible Preferred Stock) 2,067,183 Warrants to Purchase up to 2,067,183 Shares of Common Stock (and 2,067,183 Shares of Common Stock

CombiMatrix (Quarterly Report)

10-Q 1 form10-q.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For The Quarterly Period Ended March 31, 2016 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission File Number 001-3

COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION

Exhibit 10.3 COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION Warrant No.: WF-[●] Initial Exercise Date: March 24, 2016 CUSIP: 20009T147 Issue Date: March 24, 2016 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [●] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set fort

CBMX / CombiMatrix Corp. / ACUTA CAPITAL PARTNERS, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)* COMBIMATRIX CORPORATION (Name of Issuer) COM PAR (Title of Class of Securities) 20009T501 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authorized to Receive Notic

Results of Operations and Financial Condition, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporatio

CombiMatrix Corporation Reports First Quarter 2016 Financial and Operating Results Revenues Increase 28% to $3.0 Million on Record Reproductive Health Genetic Screening Test Volume and Higher Average Revenue per Test Conference Call Begins Today at 4

CombiMatrix Corporation Reports First Quarter 2016 Financial and Operating Results Revenues Increase 28% to $3.

CombiMatrix 14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by Registrant [X] Filed by a Party other than the Registrant [ ] Check the appropriate box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as permitted b

8,000 Shares of Series F Convertible Preferred Stock (and 2,067,183 Shares of Common Stock Underlying the Series F Convertible Preferred Stock) 2,067,183 Warrants to Purchase up to 2,067,183 Shares of Common Stock (and 2,067,183 Shares of Common Stoc

424B3 1 form424b3.htm Filed pursuant to Rule 424(b)(3) Registration No. 333-208704 Prospectus Supplement No. 1 (To Prospectus dated March 21, 2016) 8,000 Shares of Series F Convertible Preferred Stock (and 2,067,183 Shares of Common Stock Underlying the Series F Convertible Preferred Stock) 2,067,183 Warrants to Purchase up to 2,067,183 Shares of Common Stock (and 2,067,183 Shares of Common Stock

COMBIMATRIX CORPORATION 2016 EXECUTIVE PERFORMANCE BONUS PLAN

EX-10.1 2 ex10-1.htm EXHIBIT 10.1 COMBIMATRIX CORPORATION 2016 EXECUTIVE PERFORMANCE BONUS PLAN Purpose Pursuant to the authority granted under CombiMatrix Corporation Compensation Committee Charter, the Compensation Committee (the “Committee”) of CombiMatrix Corporation (the “Company” or “our”) has adopted this 2016 Executive Performance Bonus Plan (the “Plan”) effective as of January 1, 2016. Th

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 form8-k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorpora

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events

8-K 1 a16-707818k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of i

Certificate of Designation of Preferences, Rights and Limitations of Series F Convertible Preferred Stock. Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-33523) filed with the SEC on March 24, 2016.

EX-3.1 2 a16-70781ex3d1.htm EX-3.1 Exhibit 3.1 COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES F CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Mark McDonough and Scott R. Burell, do hereby certify that: 1. They are the President and Secretary, respectively, of CombiMatrix Corporation,

8,000 Shares of Series F Convertible Preferred Stock (and 2,067,183 Shares of Common Stock Underlying the Series F Convertible Preferred Stock) 2,067,183 Warrants to Purchase up to 2,067,183 Shares of Common Stock (and 2,067,183 Shares of Common Stoc

424B4 1 a2227916z424b4.htm 424B4 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents Filed Pursuant to Rule 424(b)(4) Registration No. 333-208704 PROSPECTUS 8,000 Shares of Series F Convertible Preferred Stock (and 2,067,183 Shares of Common Stock Underlying the Series F Convertible Preferred Stock) 2,067,183 Warrants to Purchase up to 2,067,183 Shares of Common Stoc

CombiMatrix S-1MEF

As filed with the Securities and Exchange Commission on March 21, 2016 Registration No.

CombiMatrix 8-A12B

8-A12B 1 a15-2529698a12b.htm 8-A12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 COMBIMATRIX CORPORATION (Exact name of registrant as specified in its charter) Delaware 47-0899439 (State of incorporation or organization) (I.R.S. Employer Id

LEAK-OUT AGREEMENT

Exhibit 10.49 LEAK-OUT AGREEMENT This leak-out agreement, (this ?Agreement?), dated as of March , 2016, by and between Combimatrix Corporation (the ?Company?) and the holder identified on the signature page hereto (the ?Holder?) of the Series F Convertible Preferred Stock, par value of $0.001 per share (the ?Preferred Stock?), convertible into shares of the Company?s common stock, par value $0.001

CombiMatrix S-1/A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on March 18, 2016 Registration No.

CombiMatrix S-1/A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on March 18, 2016 Registration No.

COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION

Exhibit 4.3 COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION Warrant No.: WF-[?] Initial Exercise Date: [?], 2016 CUSIP: 20009T147 Issue Date: [?], 2016 THIS COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, [?] or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any t

Incorporated Under the Laws of the State of Delaware on March 15, 2002

Exhibit 4.2 Incorporated Under the Laws of the State of Delaware on March 15, 2002 NUMBER SHARES PF-?Number? ?Shares? CUSIP 20009T 709 CombiMatrix Corporation Authorized Capital Stock 30,000,000 Shares 25,000,000 Shares Common Stock, Par Value $0.001 Per Share 5,000,000 Shares Preferred Stock, Par Value $0.001 Per Share THIS CERTIFIES THAT ? ?Name? ? is the record holder of ?AlphaNumeric? (?Shares

LEAK-OUT AGREEMENT

Exhibit 10.49 LEAK-OUT AGREEMENT This leak-out agreement, (this ?Agreement?), dated as of March , 2016, by and between Combimatrix Corporation (the ?Company?) and the holder identified on the signature page hereto (the ?Holder?) of the Series F Convertible Preferred Stock, par value of $0.001 per share (the ?Preferred Stock?), convertible into shares of the Company?s common stock, par value $0.001

COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES F CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW

EX-3.11 2 a2227786zex-311.htm EX-3.11 Exhibit 3.11 COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES F CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Mark McDonough and Scott R. Burell, do hereby certify that: 1. They are the President and Secretary, respectively, of CombiMatrix Corporat

CombiMatrix ESP

March 18, 2016 United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.

CombiMatrix ESP

March 18, 2016 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. John Reynolds and Mr. Jonathan Burr Re: CombiMatrix Corporation Registration Statement on Form S-1 (File No. 333-208704) Acceleration Request Requested Date: March 18, 2016 Requested Time: 4:30 p.m. (Eastern Time) Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations

CombiMatrix S-1/A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on March 10, 2016 Registration No.

COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES F REDEEMABLE CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW

Exhibit 3.11 COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES F REDEEMABLE CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Mark McDonough and Scott R. Burell, do hereby certify that: 1. They are the President and Secretary, respectively, of CombiMatrix Corporation, a Delaware corporation

SHARES OF SERIES F REDEEMABLE CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO AN AGGREGATE OF SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE FOR AN AGGREGATE OF SHARES OF COMMON STOCK) OF COMBIMATRIX CORPORATION UNDERWRITING AGREEMENT

Exhibit 1.1 SHARES OF SERIES F REDEEMABLE CONVERTIBLE PREFERRED STOCK (CONVERTIBLE INTO AN AGGREGATE OF SHARES OF COMMON STOCK) AND WARRANTS (EXERCISABLE FOR AN AGGREGATE OF SHARES OF COMMON STOCK) OF COMBIMATRIX CORPORATION UNDERWRITING AGREEMENT , 2016 Ladenburg Thalmann & Co. Inc. As the Representative of the Several underwriters named in Schedule I hereto 4400 Biscayne Blvd., 14th Floor Miami,

Unique Insight, Better Outcomes February 2016 NASDAQ: CBMX www.combimatrix.com

FWP 1 a15-252966fwp.htm FWP Issuer Free Writing Prospectus Dated February 19, 2016 Filed Pursuant to Rule 433 Registration No. 333-208704 Unique Insight, Better Outcomes February 2016 NASDAQ: CBMX www.combimatrix.com This presentation, the accompanying prospectus, and the information incorporated by reference herein or therein, contain forward-looking statements, within the meaning of the ‘‘safe h

Incorporated Under the Laws of the State of Delaware on March 15, 2002

EX-4.2 4 a2227339zex-42.htm EX-4.2 Exhibit 4.2 Incorporated Under the Laws of the State of Delaware on March 15, 2002 NUMBER SHARES PF-«Number» «Shares» CUSIP 20009T 709 CombiMatrix Corporation Authorized Capital Stock 30,000,000 Shares 25,000,000 Shares Common Stock, Par Value $0.001 Per Share 5,000,000 Shares Preferred Stock, Par Value $0.001 Per Share THIS CERTIFIES THAT — «Name» — is the recor

COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION

Exhibit 4.3 COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION Warrant Shares: [?] Initial Exercise Date: [?], 2016 Warrant No.: WF-[?] Issue Date: [?], 2016 CUSIP: 20009T147 THIS COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, [?] or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter

COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES F REDEEMABLE CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW

Exhibit 3.11 COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES F REDEEMABLE CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Mark McDonough and Scott R. Burell, do hereby certify that: 1. They are the President and Secretary, respectively, of CombiMatrix Corporation, a Delaware corporation

CombiMatrix S-1/A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on February 19, 2016 Registration No.

ZQ|CERT#|COY|CLS|RGSTRY|ACCT#|TRANSTYPE|RUN#|TRANS# . COMMON STOCK PAR VALUE $0.001 COMMON STOCK THIS CERTIFICATE IS TRANSFERABLE IN CANTON, MA, JERSEY CITY, NJ AND COLLEGE STATION, TX Shares * * 000000 * * * * * * * * * * * * * * * * * * * * * 00000

EX-4.1 3 a2227339zex-41.htm EX-4.1 Exhibit 4.1 ZQ|CERT#|COY|CLS|RGSTRY|ACCT#|TRANSTYPE|RUN#|TRANS# . COMMON STOCK PAR VALUE $0.001 COMMON STOCK THIS CERTIFICATE IS TRANSFERABLE IN CANTON, MA, JERSEY CITY, NJ AND COLLEGE STATION, TX Shares * * 000000 * * * * * * * * * * * * * * * * * * * * * 000000 * * * * * * * * * * * * * * * * * * * * * 000000 * * * * * * * * * * * * * * * * * * * * * 000000 * *

COMBIMATRIX CORPORATION 2006 STOCK INCENTIVE PLAN (as amended and restated June 17, 2015)(1) ARTICLE ONE GENERAL PROVISIONS

EX-10.4 2 a16-47341ex10d4.htm EX-10.4 Exhibit 10.4 COMBIMATRIX CORPORATION 2006 STOCK INCENTIVE PLAN (as amended and restated June 17, 2015)(1) ARTICLE ONE GENERAL PROVISIONS I. PURPOSE OF THE PLAN This CombiMatrix Corporation 2006 Stock Incentive Plan is intended to promote the interests of CombiMatrix Corporation, a Delaware corporation, by providing eligible persons in the Corporation’s Service

CBMX / CombiMatrix Corp. 10-K - Annual Report - 10-K

10-K 1 a16-4734110k.htm 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2015 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO . Commission F

SUBSIDIARIES OF THE REGISTRANT

EXHIBIT 21.1 SUBSIDIARIES OF THE REGISTRANT The following is a listing of the subsidiaries of CombiMatrix Corporation: Jurisdiction of Incorporation CombiMatrix Molecular Diagnostics, Inc. California

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 16, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi

CombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-implantation Genetic Screening Test Volumes Conference Call Begins T

Exhibit 99.1 CombiMatrix Corporation Reports 2015 Fourth Quarter and Full Year Financial and Operating Results Revenue Growth of 21% for the Quarter Driven by Record Miscarriage Analysis and Pre-implantation Genetic Screening Test Volumes Conference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif. (February 17, 2016) ? CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics compa

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a16-464818k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction o

CBMX / CombiMatrix Corp. / GREAT POINT PARTNERS LLC Passive Investment

SC 13G/A 1 c83977sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* Combimatrix Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 20009T501 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate t

CBMX / CombiMatrix Corp. / ACUTA CAPITAL PARTNERS, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* COMBIMATRIX CORPORTATION (Name of Issuer) COMMON STOCK (Title of Class of Securities) 20009T303 (CUSIP Number) ACUTA CAPITAL PARTNERS LLC, 1301 SHOREWAY ROAD, SUITE 350, BELMONT CA 94002 (Name, Address and Telephone Number of Person Authorized to Receive

COMBIMATRIX CORPORATION SERIES E 6% CONVERTIBLE PREFERRED STOCK REPURCHASE AGREEMENT

EX-10.1 2 a16-36341ex10d1.htm EX-10.1 Exhibit 10.1 COMBIMATRIX CORPORATION SERIES E 6% CONVERTIBLE PREFERRED STOCK REPURCHASE AGREEMENT THIS SERIES E 6% CONVERTIBLE PREFERRED STOCK REPURCHASE AGREEMENT (this “Agreement”) is made as of February 4, 2016 (the “Effective Date”), by and between CombiMatrix Corporation, a Delaware corporation (the “Company”), and the holders of Series E Preferred Stock

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 4, 2016 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissio

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

8-K 1 a15-2529658k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 29, 2016 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Comm

Certificate of Amendment to Amended and Restated Certificate of Incorporation. Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-33523) filed with the SEC on January 29, 2016.

Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THE CERTIFICATE OF INCORPORATION OF COMBIMATRIX CORPORATION Adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware CombiMatrix Corporation, (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware, by its duly authorized officer, does hereby certify: FIRST: Tha

Regulation FD Disclosure, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

8-K 1 a15-2529648k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 26, 2016 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Comm

COMBIMATRIX ANNOUNCES 1-FOR-15 REVERSE SPLIT OF COMMON STOCK Stockholders Approve Reverse Split

EX-99.1 2 a15-252964ex99d1.htm EX-99.1 Exhibit 99.1 COMBIMATRIX ANNOUNCES 1-FOR-15 REVERSE SPLIT OF COMMON STOCK Stockholders Approve Reverse Split IRVINE, Calif. (January 27, 2016) CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal, miscarriage analysis and postnatal developmental disorders and pre-implantation genetic s

CBMX / CombiMatrix Corp. / HAMILTON EDWARD ARTHUR - AMENDMENT NO. 1 Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. 1) Under the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 20009T303 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rule pursu

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 23, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi

CombiMatrix DEF 14A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS SERIES F CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW

Exhibit 3.11 COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES F CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Mark McDonough and Scott R. Burell, do hereby certify that: 1. They are the President and Secretary, respectively, of CombiMatrix Corporation, a Delaware corporation (the ?Corp

COMBIMATRIX NUMBER CBMX THIS CERTIFICATE IS TRANSFERABLE IN CANTON, MA, NEW YORK, NY, JERSEY CITY, NJ, AND PITTSBURGH, PA SHARES CUSIP 20009T 30 3 SEE REVERSE FOR CERTAIN DEFINITIONS INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE This certifies

EX-4.1 3 a2226941zex-41.htm EX-4.1 Exhibit 4.1 COMBIMATRIX NUMBER CBMX THIS CERTIFICATE IS TRANSFERABLE IN CANTON, MA, NEW YORK, NY, JERSEY CITY, NJ, AND PITTSBURGH, PA SHARES CUSIP 20009T 30 3 SEE REVERSE FOR CERTAIN DEFINITIONS INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE This certifies that SPECIMEN COUNTERSIGNED AND REGISTERED: COMPUTERSHARE SHAREOWNER SERVICES LLC TRANSFER AGENT AND R

CombiMatrix S-1

S-1 1 a2226941zs-1.htm S-1 Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents As filed with the Securities and Exchange Commission on December 22, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 COMBIMATRIX CORPORATION (Exact name of Registrant as speci

COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION

Exhibit 4.3 COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION Warrant Shares: [?] Initial Exercise Date: [?], 2016 Warrant No.: WF-[?] Issue Date: [?], 2016 CUSIP: [?] THIS COMMON STOCK PURCHASE WARRANT (the ?Warrant?) certifies that, for value received, [?] or its assigns (the ?Holder?) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set f

CombiMatrix PRE 14A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 a15-2445818k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 2, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction o

COMBIMATRIX CORPORATION RESTATED EXECUTIVE CHANGE OF CONTROL SEVERANCE PLAN

EX-10.2 3 a15-244581ex10d2.htm EX-10.2 Exhibit 10.2 COMBIMATRIX CORPORATION RESTATED EXECUTIVE CHANGE OF CONTROL SEVERANCE PLAN CombiMatrix Corporation, a Delaware corporation (the “Company”) has adopted this Executive Change of Control Severance Plan (the “Plan”), effective as of November 10, 2009, restated on August 10, 2010 and restated further on December 7, 2015, for the benefit of certain ke

COMBIMATRIX CORPORATION TRANSACTION BONUS PLAN

EX-10.1 2 a15-244581ex10d1.htm EX-10.1 Exhibit 10.1 COMBIMATRIX CORPORATION TRANSACTION BONUS PLAN 1. Purpose. CombiMatrix Corporation, a Delaware corporation (the “Company”) considers it essential to the best interests of its shareholders to induce certain employees to continue their position with the Company and to encourage such individuals to exert their very best efforts in connection with a

COMBIMATRIX CORPORATION 1,565,303 SHARES OF COMMON STOCK

424B3 1 a15-218511424b3.htm 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-207642 PROSPECTUS COMBIMATRIX CORPORATION 1,565,303 SHARES OF COMMON STOCK This prospectus relates to the resale at various times, by the selling stockholders identified in this prospectus, of up to 1,540,000 shares of Common Stock, par value $0.001 per share (“Common Stock”), issuable upon ex

CombiMatrix Corporation Reports Third Quarter 2015 Financial and Operating Results Growth in Revenue and Test Volumes Driven by Miscarriage Analysis and Pre-implantation Genetic Screening; Reports Narrowed Net Loss and Strong Cash Collections Confere

Exhibit 99.1 CombiMatrix Corporation Reports Third Quarter 2015 Financial and Operating Results Growth in Revenue and Test Volumes Driven by Miscarriage Analysis and Pre-implantation Genetic Screening; Reports Narrowed Net Loss and Strong Cash Collections Conference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif. (November 4, 2015) ? CombiMatrix Corporation (NASDAQ: CBMX), a molecular d

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissio

CombiMatrix ESP

November 3, 2015 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Michael Killoy Re: CombiMatrix Corporation Registration Statement on Form S-3 (File No. 333-207642) Acceleration Request Requested Date: November 6, 2015 Requested Time: 4:00 p.m. (Eastern Time) Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

424B3 1 a15-217877424b3.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration No. 333-187945 Prospectus Supplement No. 2 dated October 28, 2015 (To Prospectus dated April 30, 2013) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated April 30, 2013, as supplemented by the prospectus supplement dated June 10, 2014, in order to reflect an

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

424B3 1 a15-217871424b3.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration No. 333-188682 Prospectus Supplement dated October 28, 2015 (To Prospectus dated May 29, 2013) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated May 29, 2013 in order to reflect an amendment to certain provisions of the warrants described therein (the “Warr

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-189759 Prospectus Supplement No. 2 dated October 28, 2015 (To Prospectus dated July 11, 2013) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated July 11, 2013, as supplemented by the prospectus supplement dated June 10, 2014, in order to reflect an amendment to certain provisions of

COMBIMATRIX CORPORATION Warrants to Purchase 275,000 Shares of Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-176372 Registration No. 333-198848 Prospectus Supplement dated October 28, 2015 (To Prospectus dated October 2, 2014) COMBIMATRIX CORPORATION Warrants to Purchase 275,000 Shares of Common Stock This prospectus supplement amends the prospectus dated October 2, 2014 in order to reflect an amendment to certain provisions of the March 2013 warrants

CombiMatrix S-3

Table of Contents As filed with the Securities and Exchange Commission on October 28, 2015 Registration No.

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-185585 Prospectus Supplement No. 3 dated October 28, 2015 (To Prospectus dated January 7, 2013) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated January 7, 2013, as supplemented by the prospectus supplements dated February 26, 2013 and June 10, 2014, in order to reflect an amendmen

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-193148 Prospectus Supplement No. 2 dated October 28, 2015 (To Prospectus dated March 7, 2014) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated March 7, 2014, as supplemented by the prospectus supplement dated June 10, 2014, in order to reflect an amendment to certain provisions of

COMBIMATRIX CORPORATION Warrants to Purchase 275,000 Shares of Common Stock

424B3 1 a15-217875424b3.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration No. 333-176372 Registration No. 333-198848 Prospectus Supplement dated October 28, 2015 (To Prospectus dated October 2, 2014) COMBIMATRIX CORPORATION Warrants to Purchase 275,000 Shares of Common Stock This prospectus supplement amends the prospectus dated October 2, 2014 in order to reflect an amendment to certain pro

Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Financial Statements and Exhibits

8-K 1 a15-2100028k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 12, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction o

COMBIMATRIX CORPORATION AMENDMENT NO. 1 TO APRIL 2015 COMMON STOCK PURCHASE WARRANTS WARRANT NO.: «Warrant_No» THIS AMENDMENT SHOULD BE ATTACHED TO THE ORIGINAL WARRANT CERTIFICATES

EX-10.2 3 a15-210002ex10d2.htm EX-10.2 EXHIBIT 10.2 COMBIMATRIX CORPORATION AMENDMENT NO. 1 TO APRIL 2015 COMMON STOCK PURCHASE WARRANTS WARRANT NO.: «WarrantNo» THIS AMENDMENT SHOULD BE ATTACHED TO THE ORIGINAL WARRANT CERTIFICATES THIS AMENDMENT NO. 1 TO APRIL 2015 COMMON STOCK PURCHASE WARRANTS (this “Amendment”) is made as of October 12, 2015 by and between CombiMatrix Corporation, a Delaware

COMBIMATRIX CORPORATION AMENDMENT NO. 1 TO FEBRUARY 2015 COMMON STOCK PURCHASE WARRANTS WARRANT NO.: «Warrant_No» THIS AMENDMENT SHOULD BE ATTACHED TO THE ORIGINAL WARRANT CERTIFICATES

EX-10.1 2 a15-210002ex10d1.htm EX-10.1 EXHIBIT 10.1 COMBIMATRIX CORPORATION AMENDMENT NO. 1 TO FEBRUARY 2015 COMMON STOCK PURCHASE WARRANTS WARRANT NO.: «WarrantNo» THIS AMENDMENT SHOULD BE ATTACHED TO THE ORIGINAL WARRANT CERTIFICATES THIS AMENDMENT NO. 1 TO FEBRUARY 2015 COMMON STOCK PURCHASE WARRANTS (this “Amendment”) is made as of October 12, 2015 by and between CombiMatrix Corporation, a Del

COMBIMATRIX CORPORATION Warrants to Purchase 700,000 Shares of Common Stock

424B3 1 a15-210001424b3.htm 424B3 Filed pursuant to Rule 424(b)(3) Registration No. 333-198848 Prospectus Supplement dated October 12, 2015 (To Prospectus dated October 2, 2014, as Supplemented on February 12, 2015) COMBIMATRIX CORPORATION Warrants to Purchase 700,000 Shares of Common Stock This prospectus supplement amends the prospectus dated October 2, 2014, as supplemented on February 12, 2015

[Signature Pages Follow]

EXHIBIT 10.3 October 12, 2015 CombiMatrix Corporation Attn: Scott Burell 310 Goddard, Suite 150 Irvine, CA 92618 Gentlemen: Reference is made to those certain Securities Purchase Agreements dated as of September 28, 2012, March 19, 2013, May 3, 2013 and February 13, 2015, respectively, by and among CombiMatrix Corporation, a Delaware corporation (the ?Company?), Alpha Capital Anstalt and the other

CombiMatrix Corporation Reports Second Quarter 2015 Financial and Operating Results Marks 7th Consecutive Quarter of Record Prenatal Microarray Test Revenues and Volumes Conference Call Begins Today at 4:30 p.m. Eastern Time

Exhibit 99.1 CombiMatrix Corporation Reports Second Quarter 2015 Financial and Operating Results Marks 7th Consecutive Quarter of Record Prenatal Microarray Test Revenues and Volumes Conference Call Begins Today at 4:30 p.m. Eastern Time IRVINE, Calif. (August 5, 2015) ? CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics company specializing in DNA-based testing services for prenatal

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a15-1685118k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 5, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of

CombiMatrix S-8

S-8 1 a15-152871s8.htm S-8 As filed with the Securities and Exchange Commission on July 9, 2015 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 COMBIMATRIX CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 47-0899439 (State or Other Jurisdiction (IRS Employer Ide

COMBIMATRIX CORPORATION 2006 STOCK INCENTIVE PLAN (as amended and restated June 17, 2015) ARTICLE ONE GENERAL PROVISIONS

EX-10.1 2 a15-144001ex10d1.htm EX-10.1 Exhibit 10.1 COMBIMATRIX CORPORATION 2006 STOCK INCENTIVE PLAN (as amended and restated June 17, 2015) ARTICLE ONE GENERAL PROVISIONS I. PURPOSE OF THE PLAN This CombiMatrix Corporation 2006 Stock Incentive Plan is intended to promote the interests of CombiMatrix Corporation, a Delaware corporation, by providing eligible persons in the Corporation’s Service w

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

8-K 1 a15-1440018k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2015 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Commiss

CombiMatrix DEFA14A

DEFA14A 1 a15-135041defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide

CombiMatrix Reports First Quarter 2015 Financial and Operating Results Record Prenatal Microarray Volumes and Revenue Growth, Record Cash Collections and Traction of New Tests Highlight a Strong Quarter of Commercial Execution — Company to Host Confe

Exhibit 99.1 CombiMatrix Reports First Quarter 2015 Financial and Operating Results Record Prenatal Microarray Volumes and Revenue Growth, Record Cash Collections and Traction of New Tests Highlight a Strong Quarter of Commercial Execution ? Company to Host Conference Call and Webcast Today at 1:30 p.m. PDT ? IRVINE, Calif. ? May 7, 2015 ? CombiMatrix Corporation (Nasdaq: CBMX), a molecular diagno

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission Fil

Certificate of Amendment to Amended and Restated Certificate of Incorporation. Incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K (File No. 001-33523) filed with the SEC on April 29, 2015.

Exhibit 3.1 CERTIFICATE OF AMENDMENT OF THE CERTIFICATE OF INCORPORATION OF COMBIMATRIX CORPORATION Adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware CombiMatrix Corporation, (the ?Corporation?), a corporation organized and existing under the laws of the State of Delaware, by its duly authorized officer, does hereby certify: FIRST: Tha

CombiMatrix DEF 14A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Unregistered Sales of Equity Securities, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

8-K 1 a15-1024818k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 28, 2015 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Commis

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission

AGREEMENT OF SETTLEMENT AND RELEASE

EX-10.1 2 a15-100561ex10d1.htm EX-10.1 Exhibit 10.1 AGREEMENT OF SETTLEMENT AND RELEASE This AGREEMENT OF SETTLEMENT AND RELEASE (the “Agreement”) is made and entered into as of April 23, 2015 (the “Effective Date”), by and between Plaintiff Michael Strathmann (“Strathmann” or “Plaintiff”), on the one hand, and Defendants Acacia Research Corporation, a Delaware corporation (“Acacia”) CombiMatrix C

CBMX / CombiMatrix Corp. / HAMILTON EDWARD ARTHUR Passive Investment

SC 13G 1 j422150sc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 CombiMatrix Corporation (Name of Issuer) Common Stock, $0.001 par value (Title of Class of Securities) 20009T303 (CUSIP Number) January 22, 2015 (Date of Event Which Requires Filing of This Statement) Check the appropriate box to designate the rul

CombiMatrix 8-K/A (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) April 16, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorpor

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 12, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission F

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 12, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission

CombiMatrix DEF 14A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

COMBIMATRIX CORPORATION 2015 EXECUTIVE PERFORMANCE BONUS PLAN

EXHIBIT 10.1 COMBIMATRIX CORPORATION 2015 EXECUTIVE PERFORMANCE BONUS PLAN Purpose Pursuant to the authority granted under CombiMatrix Corporation Compensation Committee Charter, the Compensation Committee (the “Committee”) of CombiMatrix Corporation (the “Company” or “our”) has adopted this 2015 Executive Performance Bonus Plan (the “Plan”) effective as of January 1, 2015. The purpose of this Pla

CombiMatrix 8-K (Current Report/Significant Event)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 27, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi

CBMX / CombiMatrix Corp. PRE 14A - - PRE 14A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

Financial Statements and Exhibits, Results of Operations and Financial Condition

8-K 1 a15-523518k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 25, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction o

CombiMatrix Reports Fourth Quarter and Full Year 2014 Financial and Operating Results — Company to Host Conference Call and Webcast Today at 1:30 p.m. PST —

Exhibit 99.1 CombiMatrix Reports Fourth Quarter and Full Year 2014 Financial and Operating Results — Company to Host Conference Call and Webcast Today at 1:30 p.m. PST — IRVINE, Calif. — February 25, 2015 — CombiMatrix Corporation (Nasdaq: CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal developmental disorders, today reported financial resul

CBMX / CombiMatrix Corp. / ALPHA CAPITAL ANSTALT - SCHEDULE 13G AMENDMENT NO. 2 Passive Investment

SC 13G/A 1 sc13g0215a2alphacombimatrix.htm SCHEDULE 13G AMENDMENT NO. 2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 2) COMBIMATRIX CORPORATION (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 20009T303 (CUSIP Number) Check the appropriate box to designate the rule pursuant

CBMX / CombiMatrix Corp. / GREAT POINT PARTNERS LLC Passive Investment

SC 13G/A 1 c80287sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* Combimatrix Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 20009T303 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate t

Incorporated Under the laws of the state of Delaware on march 15, 2002 Number shares per number shares combimatrix corporation Authorized capital stock 30,000,000 shares 25,000,000 shares common stock, par value $0.001 per share 5,000,000 shares of p

Exhibit 4.2 Incorporated Under the laws of the state of Delaware on march 15, 2002 Number shares per number shares combimatrix corporation Authorized capital stock 30,000,000 shares 25,000,000 shares common stock, par value $0.001 per share 5,000,000 shares of preferred stock, par Value $0.001 per share This certifies that – name – is the record holder of alphanumeric (shares) shares of series E 6

Regulation FD Disclosure, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi

SECURITIES PURCHASE AGREEMENT

Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 13, 2015, between CombiMatrix Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and condit

1,542,000 SHARES OF COMMON STOCK 2,201.50 SHARES OF SERIES E 6% CONVERTIBLE PREFERRED STOCK 1,258,000 SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THE SERIES E 6% CONVERTIBLE PREFERRED STOCK WARRANTS TO PURCHASE 700,000 SHARES OF COMMON STOCK 7

424B5 1 a15-45473424b5.htm 424B5 Table of Contents Filed Pursuant to Rule 424(b)(5) Registration No. 333-198848 PROSPECTUS SUPPLEMENT (TO PROSPECTUS DATED OCTOBER 2, 2014) 1,542,000 SHARES OF COMMON STOCK 2,201.50 SHARES OF SERIES E 6% CONVERTIBLE PREFERRED STOCK 1,258,000 SHARES OF COMMON STOCK ISSUABLE UPON CONVERSION OF THE SERIES E 6% CONVERTIBLE PREFERRED STOCK WARRANTS TO PURCHASE 700,000 SH

COMBIMATRIX CORPORATION AMENDMENT NO. TO COMMON STOCK PURCHASE WARRANTS THIS AMENDMENT SHOULD BE ATTACHED TO THE ORIGINAL WARRANT CERTIFICATES

Exhibit 4.5 COMBIMATRIX CORPORATION AMENDMENT NO. TO COMMON STOCK PURCHASE WARRANTS THIS AMENDMENT SHOULD BE ATTACHED TO THE ORIGINAL WARRANT CERTIFICATES THIS AMENDMENT NO. TO COMMON STOCK PURCHASE WARRANTS (this “Amendment”) is made as of February 13, 2015 by and between CombiMatrix Corporation, a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of those certain Co

COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION

Exhibit 4.4 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTR

SECURITIES PURCHASE AGREEMENT

Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of February 13, 2015, between CombiMatrix Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and condit

Certificate of Designation of Preferences, Rights and Limitations of Series E 6% Convertible Preferred Stock. Incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K (File No. 001-33523) filed with the SEC on February 13, 2015.

Exhibit 4.1 COMBIMATRIX CORPORATION CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SERIES E 6% CONVERTIBLE PREFERRED STOCK PURSUANT TO SECTION 151 OF THE DELAWARE GENERAL CORPORATION LAW The undersigned, Mark McDonough and Scott R. Burell, do hereby certify that: 1. They are the President and Secretary, respectively, of CombiMatrix Corporation, a Delaware corporation (the “Co

COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION Warrant Shares: Initial Exercise Date: August , 2015 Issue Date: February , 2015

Exhibit 4.3 COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION Warrant Shares: Initial Exercise Date: August , 2015 Issue Date: February , 2015 THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after

COMBIMATRIX ANNOUNCES $4.9 MILLION REGISTERED DIRECT OFFERING Agreement Executed for the Sale of Common and Convertible Preferred Stock and Warrants

Exhibit 99.1 COMBIMATRIX ANNOUNCES $4.9 MILLION REGISTERED DIRECT OFFERING Agreement Executed for the Sale of Common and Convertible Preferred Stock and Warrants IRVINE, California, February 13, 2015 (GLOBE NEWSWIRE) — CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disorders and cancer diagnostics, announced toda

CBMX / CombiMatrix Corp. / ACUTA CAPITAL PARTNERS, LLC Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* COMBIMATRIX CORPORATION (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 20009T303 (CUSIP Number) LONGWOOD CAPITAL PARTNERS LLC, 3200 ALPINE ROAD, PORTOLA VALLEY CA 94028 TEL: 415-308-9415 (Name, Address and Telephone Number o

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2015 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 14, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi

CombiMatrix Promotes Karine Hovanes, Ph.D., to Vice President of Scientific Advancement and Laboratory Director, and Trilochan Sahoo, M.D., to Vice President of Clinical Affairs and Director of Cytogenetics Assuming Responsibilities of R. Weslie Tyso

Exhibit 99.1 CombiMatrix Promotes Karine Hovanes, Ph.D., to Vice President of Scientific Advancement and Laboratory Director, and Trilochan Sahoo, M.D., to Vice President of Clinical Affairs and Director of Cytogenetics Assuming Responsibilities of R. Weslie Tyson, M.D., Chief Medical Officer, Who Will Retire on December 12, 2014 IRVINE, California, November 19, 2014 (GLOBE NEWSWIRE) — CombiMatrix

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissio

CombiMatrix Reports Third Quarter 2014 Financial and Operating Results — Reports Record Revenue, Cash Reimbursement and Test Volumes — — Company to Host Conference Call and Webcast Today at 1:30 p.m. PST —

Exhibit 99.1 CombiMatrix Reports Third Quarter 2014 Financial and Operating Results — Reports Record Revenue, Cash Reimbursement and Test Volumes — — Company to Host Conference Call and Webcast Today at 1:30 p.m. PST — IRVINE, Calif. — November 4, 2014 — CombiMatrix Corporation (Nasdaq: CBMX), a molecular diagnostics company specializing in DNA-based testing services for pre- and postnatal develop

AMENDMENT NO. 6 TO THE LEASE

EX-10.1 2 a14-230641ex10d1.htm EX-10.1 Exhibit 10.1 AMENDMENT NO. 6 TO THE LEASE This AMENDMENT NO. 6 TO THE LEASE (this “Amendment No. 6”) dated September 23, 2014 for reference purposes only, is made by and between PPC Goddard Investment, LLC, a California limited liability company (“Lessor”) successor in interest from GFE Goddard Investment, LLC successor in interest through a Grant Deed from E

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

8-K 1 a14-2306418k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction o

CBMX / CombiMatrix Corp. S-3 - - S-3

S-3 1 a14-211941s3.htm S-3 Table of Contents As filed with the Securities and Exchange Commission on September 19, 2014 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 COMBIMATRIX CORPORATION (Exact name of Registrant as specified in its charter) Delaware 47-0899439 (State or other jurisd

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commiss

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 12, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commiss

Financial Statements and Exhibits, Results of Operations and Financial Condition

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission

CBMX / CombiMatrix Corp. S-8 - - S-8

As filed with the Securities and Exchange Commission on July 9, 2014 Registration No.

COMBIMATRIX CORPORATION 2006 STOCK INCENTIVE PLAN (as amended and restated June 17, 2014) ARTICLE ONE GENERAL PROVISIONS

EX-99.1 4 a14-160651ex99d1.htm EX-99.1 Exhibit 99.1 COMBIMATRIX CORPORATION 2006 STOCK INCENTIVE PLAN (as amended and restated June 17, 2014) ARTICLE ONE GENERAL PROVISIONS I. PURPOSE OF THE PLAN This CombiMatrix Corporation 2006 Stock Incentive Plan is intended to promote the interests of CombiMatrix Corporation, a Delaware corporation, by providing eligible persons in the Corporation’s Service w

Submission of Matters to a Vote of Security Holders

8-K 1 a14-1578518k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 17, 2014 CombiMatrix Corporation (Exact Name of Registrant as Specified in Charter) Delaware 001-33523 47-0899439 (State or Other Jurisdiction (Commiss

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (a

COMBIMATRIX CORPORATION AMENDMENT NO. 2 TO COMMON STOCK PURCHASE WARRANTS THIS AMENDMENT SHOULD BE ATTACHED TO THE ORIGINAL WARRANT CERTIFICATES

EXHIBIT 10.1 COMBIMATRIX CORPORATION AMENDMENT NO. 2 TO COMMON STOCK PURCHASE WARRANTS THIS AMENDMENT SHOULD BE ATTACHED TO THE ORIGINAL WARRANT CERTIFICATES THIS AMENDMENT NO. 2 TO COMMON STOCK PURCHASE WARRANTS (this “Amendment”) is made as of the last date set forth below by and between CombiMatrix Corporation, a Delaware corporation (the “Company”), and the undersigned holder (the “Holder”) of

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-193148 Prospectus Supplement dated June 10, 2014 (To Prospectus dated March 7, 2014) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated March 7, 2014 in order to reflect an amendment to certain provisions of the warrants described therein (the “Warrants”) to purchase shares of our Co

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-189759 Prospectus Supplement dated June 10, 2014 (To Prospectus dated July 11, 2013) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated July 11, 2013 in order to reflect an amendment to certain provisions of the warrants described therein (the “Warrants”) to purchase shares of our Co

COMMON STOCK PURCHASE WARRANT COMBIMATRIX CORPORATION

EX-10.2 3 a14-149511ex10d2.htm EX-10.2 EXHIBIT 10.2 NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-185585 Prospectus Supplement dated June 10, 2014 (To Prospectus dated January 7, 2013) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated January 7, 2013 in order to reflect an amendment to certain provisions of the warrants described therein (the “Warrants”) to purchase shares of ou

Entry into a Material Definitive Agreement, Material Modification to Rights of Security Holders, Unregistered Sales of Equity Securities, Financial Statements and Exhibits - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission Fi

COMBIMATRIX CORPORATION Warrants to Purchase Common Stock

Filed pursuant to Rule 424(b)(3) Registration No. 333-187945 Prospectus Supplement dated June 10, 2014 (To Prospectus dated April 30, 2013) COMBIMATRIX CORPORATION Warrants to Purchase Common Stock This prospectus supplement amends the prospectus dated April 30, 2013 in order to reflect an amendment to certain provisions of the warrants described therein (the “Warrants”) to purchase shares of our

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (a

5,825,243 Shares of Common Stock Issuable Upon Exercise of December 2013 Warrants

Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-191211 PROSPECTUS 5,825,243 Shares of Common Stock Issuable Upon Exercise of December 2013 Warrants This prospectus relates to 5,825,243 shares of our common stock issuable upon the exercise of our outstanding December 2013 warrants. The December 2013 warrants were offered and sold by us pursuant to a prospectus dated December

COMBIMATRIX CORPORATION REPORTS RECORD REVENUES FOR 2014 FIRST QUARTER Prenatal Microarray Test Volumes and Revenues Reach Record Levels, Up Year-over-Year 60% and 34%, Respectively Total Microarray Revenue Up Sequentially 9% from Q4 2013 to Q1 2014

Exhibit 99.1 COMBIMATRIX CORPORATION REPORTS RECORD REVENUES FOR 2014 FIRST QUARTER Prenatal Microarray Test Volumes and Revenues Reach Record Levels, Up Year-over-Year 60% and 34%, Respectively Total Microarray Revenue Up Sequentially 9% from Q4 2013 to Q1 2014 IRVINE, California, May 7, 2014 (GLOBE NEWSWIRE) — CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics company specializing i

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commission Fil

- DEF 14A

Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.

- DEFA14A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (RULE 14a-101) SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (a

- RW

VIA EDGAR AND FEDEX April 28, 2014 Securities and Exchange Commission 100 F Street, N.

- POS AM

Table of Contents As filed with the Securities and Exchange Commission on April 28, 2014 Registration No.

- POS AM

As filed with the Securities and Exchange Commission on March 24, 2014 Registration Statement No.

CombiMatrix 10-K (Annual Report)

10-K 1 a2218684z10-k.htm 10-K Use these links to rapidly review the document TABLE OF CONTENTS INDEX TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2013 OR o TRANSITION REPORT PURSUANT T

March 3, 2014

EX-10.1 2 a14-77271ex10d1.htm EX-10.1 Exhibit 10.1 March 3, 2014 Wes Tyson, MD (Personal Address) Re: Offer Letter Dear Wes: I am delighted to offer to you the Chief Medical Officer position with CombiMatrix (or “the Company”), reporting directly to me. The purpose of this letter is to set forth the terms of your offer, which if you accept, will become your initial employment terms. You will be ex

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

8-K 1 a14-772718k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 5, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of inc

COMBIMATRIX HIRES R. WESLIE TYSON, M.D., AS CHIEF MEDICAL OFFICER Veteran Pediatric and Perinatal Pathologist with Strong Focus on Recurrent Pregnancy Loss

EX-99.1 4 a14-77271ex99d1.htm EX-99.1 Exhibit 99.1 COMBIMATRIX HIRES R. WESLIE TYSON, M.D., AS CHIEF MEDICAL OFFICER Veteran Pediatric and Perinatal Pathologist with Strong Focus on Recurrent Pregnancy Loss IRVINE, California, March 10, 2014 (GLOBE NEWSWIRE) — CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics company specializing in DNA-based testing services for developmental disord

2014 EXECUTIVE PERFORMANCE BONUS PLAN

EX-10.2 3 a14-77271ex10d2.htm EX-10.2 Exhibit 10.2 2014 EXECUTIVE PERFORMANCE BONUS PLAN Purpose Pursuant to the authority granted under CombiMatrix Corporation Compensation Committee Charter, the Compensation Committee (the “Committee”) of CombiMatrix Corporation (the “Company” or “our”) has adopted this 2014 Executive Performance Bonus Plan (the “Plan”) effective as of January 1, 2014. The purpo

COMBIMATRIX CORPORATION 81,910 SHARES OF COMMON STOCK

424B3 1 a13-271581424b3.htm 424B3 Table of Contents Filed Pursuant to Rule 424(b)(3) Registration No. 333-193148 PROSPECTUS COMBIMATRIX CORPORATION 81,910 SHARES OF COMMON STOCK This prospectus relates to the resale at various times, by the selling stockholders identified in this prospectus, of up to 81,910 shares (“Shares”) of Common Stock, par value $0.001 per share (“Common Stock”), issuable, a

-

March 4, 2014 VIA EDGAR Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Attention: Joe McCann Re: CombiMatrix Corporation Registration Statement on Form S-3 (File No. 333-193148) Acceleration Request Requested Date: March 6, 2014 Requested Time: 4:00 p.m. (Eastern Time) Ladies and Gentlemen: Pursuant to Rule 461 of the General Rules and Regulations under the Securities

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 a14-657318k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction o

COMBIMATRIX CORPORATION STOCK AWARD AGREEMENT

EXHIBIT 10.2 COMBIMATRIX CORPORATION STOCK AWARD AGREEMENT This STOCK AWARD AGREEMENT (this “Agreement”), dated as of , (the “Effective Date”), is between CombiMatrix Corporation, a Delaware corporation (the “Company”) and , an individual resident of (“Participant”). This Stock Award is granted under the CombiMatrix Corporation 2006 Stock Incentive Plan (the “Plan”) and is subject to the terms of

2014 EXECUTIVE PERFORMANCE BONUS PLAN

EX-10.1 2 a14-65731ex10d1.htm EX-10.1 Exhibit 10.1 2014 EXECUTIVE PERFORMANCE BONUS PLAN Purpose Pursuant to the authority granted under CombiMatrix Corporation Compensation Committee Charter, the Compensation Committee (the “Committee”) of CombiMatrix Corporation (the “Company” or “our”) has adopted this 2014 Executive Performance Bonus Plan (the “Plan”) effective as of January 1, 2014. The purpo

COMBIMATRIX CORPORATION REPORTS RESULTS FOR 2013 FOURTH QUARTER AND FULL YEAR Record Revenue and Microarray Volumes Continue in Q4; 57% Year-over-Year prenatal array revenue growth in Q4; 21.8% prenatal array revenue growth from Q3 to Q4 2013

Exhibit 99.1 COMBIMATRIX CORPORATION REPORTS RESULTS FOR 2013 FOURTH QUARTER AND FULL YEAR Record Revenue and Microarray Volumes Continue in Q4; 57% Year-over-Year prenatal array revenue growth in Q4; 21.8% prenatal array revenue growth from Q3 to Q4 2013 IRVINE, California, February 19, 2014 (GLOBE NEWSWIRE) — CombiMatrix Corporation (NASDAQ: CBMX), a molecular diagnostics company specializing in

Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 19, 2014 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi

CBMX / CombiMatrix Corp. / GREAT POINT PARTNERS LLC Passive Investment

SC 13G 1 c76437sc13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Combimatrix Corporation (Name of Issuer) Common Stock (Title of Class of Securities) 20009T303 (CUSIP Number) February 5, 2014 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule

- S-3/A

Table of Contents As filed with the Securities and Exchange Commission on February 4, 2014 Registration No.

-

February 4, 2014 VIA EDGAR AND FEDERAL EXPRESS Securities and Exchange Commission 100 F Street, N.

- S-8

S-8 1 a14-31721s8.htm S-8 As filed with the Securities and Exchange Commission on January 10, 2014 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 COMBIMATRIX CORPORATION (Exact Name of Registrant as Specified in Its Charter) Delaware 47-0899439 (State or Other Jurisdiction (IRS Employer

CBMX / CombiMatrix Corp. / ACUTA CAPITAL PARTNERS, LLC Passive Investment

SC 13G 1 form13g.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* COMBIMATRIX CORPORATION (Name of Issuer) COMMON STOCK, $.001 PAR VALUE (Title of Class of Securities) 20009T303 (CUSIP Number) (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) JANUARY 3,

- S-3

S-3 1 a13-271581s3.htm S-3 Table of Contents As filed with the Securities and Exchange Commission on December 31, 2013 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 COMBIMATRIX CORPORATION (Exact name of Registrant as specified in its charter) Delaware 47-0899439 (State or other jurisdi

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Material Modification to Rights of Security Holders, Financial Statements and Exhibits, Other Events - 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 17, 2013 CombiMatrix Corporation (Exact name of registrant as specified in its charter) Delaware 001-33523 47-0899439 (State or other jurisdiction of incorporation) (Commissi